[go: up one dir, main page]

ATE204606T1 - Prohormon konvertase transformierte zellen. - Google Patents

Prohormon konvertase transformierte zellen.

Info

Publication number
ATE204606T1
ATE204606T1 AT93900978T AT93900978T ATE204606T1 AT E204606 T1 ATE204606 T1 AT E204606T1 AT 93900978 T AT93900978 T AT 93900978T AT 93900978 T AT93900978 T AT 93900978T AT E204606 T1 ATE204606 T1 AT E204606T1
Authority
AT
Austria
Prior art keywords
transformed cells
polypeptide
prohormone convertase
prorelaxin
nucleic acid
Prior art date
Application number
AT93900978T
Other languages
English (en)
Inventor
Cornelia M Gorman
Debyra J Groskreutz
David Marriott
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE204606T1 publication Critical patent/ATE204606T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT93900978T 1991-12-06 1992-12-04 Prohormon konvertase transformierte zellen. ATE204606T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80363191A 1991-12-06 1991-12-06
US88726592A 1992-05-22 1992-05-22
PCT/US1992/010621 WO1993011247A1 (en) 1991-12-06 1992-12-04 Prohormone convertase transformed cells

Publications (1)

Publication Number Publication Date
ATE204606T1 true ATE204606T1 (de) 2001-09-15

Family

ID=27122612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900978T ATE204606T1 (de) 1991-12-06 1992-12-04 Prohormon konvertase transformierte zellen.

Country Status (9)

Country Link
EP (2) EP0616645B1 (de)
JP (1) JPH07501703A (de)
AT (1) ATE204606T1 (de)
CA (1) CA2123430C (de)
DE (1) DE69232017T2 (de)
DK (1) DK0616645T3 (de)
ES (1) ES2160591T3 (de)
PT (1) PT616645E (de)
WO (1) WO1993011247A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348327B1 (en) 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
SG47030A1 (en) * 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
US8147844B1 (en) 1994-01-03 2012-04-03 Genentech, Inc. Mpl ligand (thrombopoietin), nucleic acids encoding such, and methods of treatment using mpl ligand
US6660256B1 (en) 1994-01-03 2003-12-09 Genetech, Inc. Porcine mpl ligand
US8192955B1 (en) 1994-01-03 2012-06-05 Genentech, Inc. Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof
US8241900B1 (en) 1994-01-03 2012-08-14 Genentech, Inc. mpl ligand
US8357513B1 (en) 1994-01-03 2013-01-22 Genentech, Inc. Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
IL139335A (en) * 1994-01-03 2005-08-31 Genentech Inc Mpl ligand polypeptides, nucleic acids encoding them, vectors and host cells comprising such nucleic acids, processes for producing such polypeptides pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating thrombocytopenia
US8278099B1 (en) 1994-02-15 2012-10-02 Genentech, Inc. Monoclonal antibody to human thrombopoietin
CA2188675A1 (en) * 1994-04-11 1995-10-19 Savio L. C. Woo Compositions and methods for gene therapy to treat disease
AUPN442295A0 (en) 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
JPH09295945A (ja) * 1996-04-30 1997-11-18 Hoechst Yakuhin Kogyo Kk 成熟型骨誘導因子の製造方法
WO1998005782A1 (en) * 1996-08-02 1998-02-12 Zymogenetics, Inc. Testis-specific insulin homolog polypeptides
US6709659B1 (en) 1996-08-02 2004-03-23 Zymogenetics, Inc. Antibodies that bind testis-specific insulin homolog polypeptides
WO1998027210A1 (en) * 1996-12-16 1998-06-25 Zymogenetics, Inc. Compositions and methods for stimulating pancreatic islet cell regeneration
US20080187954A1 (en) * 2004-03-10 2008-08-07 Lonza Ltd. Method For Producing Antibodies
US8188335B2 (en) 2009-07-17 2012-05-29 Abbott Laboratories Δ9-elongase for production of polyunsaturated fatty acid-enriched oils
EP2719393B1 (de) 2011-06-07 2020-10-21 Asahi Kasei Pharma Corporation Gefriergetrocknetes präparat mit hochreinem pth und herstellungsverfahren dafür
US11230583B2 (en) 2015-11-26 2022-01-25 Hudson Institute of Medical Research Inhibin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87737A (en) * 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
JP2643968B2 (ja) * 1988-02-03 1997-08-25 サントリー株式会社 Ｋｅｘ２エンドプロテアーゼ及びその製造方法
EP0470976B1 (de) * 1989-05-04 1993-03-31 Genentech, Inc. Verfahren und zusammensetzungen zur isolation von menschlichem relaxin

Also Published As

Publication number Publication date
DE69232017T2 (de) 2002-03-21
DK0616645T3 (da) 2001-10-08
JPH07501703A (ja) 1995-02-23
EP0616645B1 (de) 2001-08-22
CA2123430A1 (en) 1993-06-10
WO1993011247A1 (en) 1993-06-10
CA2123430C (en) 2004-02-10
EP0616645A1 (de) 1994-09-28
DE69232017D1 (de) 2001-09-27
EP1099758A2 (de) 2001-05-16
ES2160591T3 (es) 2001-11-16
PT616645E (pt) 2002-02-28
EP1099758A3 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
ATE204606T1 (de) Prohormon konvertase transformierte zellen.
ES8507179A1 (es) Un metodo de conseguir una deseada proteina madura en una celula hospedante de vertebrado.
IT8721107A0 (it) Dell'anidride carbonica. reattore fotobiologico con sistema perfezionato di alimentazione
NO175266C (no) Fremgangsmåte for fremstilling av et humant t-PA protein som mangler en eller flere av de N-bundne karbohydratrestene, DNA, hybridvektor samt transformert eukaryot vertscelle som er i stand til å uttrykke et humant t-PA protein
DK188987D0 (da) Termostatsyret blandingsbatteri, isaer til brugsvand
DK0584452T3 (da) Nye amyloid forstadieproteiner samt fremgangsmåder til anvendelse af samme
ATE238167T1 (de) Verglazung mit einer activen thermische, elektrische und/oder elektrochemische einheit
DE3852074D1 (de) Verfahren zur reinigung von rekombinanten polypeptiden.
DK127786A (da) Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertsceller indeholdende vektorerne
FI885679A0 (fi) Samuttryckning i eukariotiska celler.
DK595286D0 (da) Fremgangsmaade til fremstilling af thrombininhibitorer
DE68926569D1 (de) Cho-zellen befähigt enzymatisch aktive rekombinante-glukocerebrosidase zu produzieren
KR880700855A (ko) 진핵생물 단백질을 발현시키는 개선된 방법
DK427985A (da) Fremgangsmaade til optisk paavisning af et protein eller en nucleinsyre i en matrix
AU5520390A (en) Dna coding for protein capable of combining with enhancer of alpha-fetoprotein gene
MX157287A (es) Celda electroquimica mejorada con anodo gelificado
NO163070C (no) Fortykket vandig saltsyre-blanding omfattende saltsyre, et alkohol-etoksylat og en arylsulfonsyre og anvendelse derav.
DE3689959D1 (de) Weiche Kontaktlinse mit hoher Wasserabsorption.
ES2031977T3 (es) Procedimiento para la obtencion de soluciones diluidas de acidos percaboxilicos.
ES2187514T3 (es) Colesterol-7-alfa-hidroxilasa humana truncada, metodo de produccion y uso de la misma.
MX9303788A (es) Procedimiento para preparar esteres granulados.
BR8503509A (pt) Ester de metila de acido n-benzil azetidina 3-carboxilico seu uso;processo para sua preparacao e acido n-benzil azetidina-3-carboxilico
SU626270A1 (ru) Универсальный шарнир
SU1183892A1 (ru) Способ определени никел
DK454286D0 (da) Fremgangsmaade til stabil ekspression af en fremmed polypeptidkodendesekvens samt hermed transformerede e. coli-celler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee